Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
418 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center-Metro Medical Center Bayamon
Bayamón, Puerto Rico
- Doctors Cancer Center
Manati, Puerto Rico
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- San Juan Community Oncology Group
San Juan, Puerto Rico
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Tower Cancer Research Foundation
Beverly Hills, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- Fresno Cancer Center
Fresno, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Pomona Valley Hospital Medical Center
Pomona, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Kaiser Permanente- Marshall Medical Offices
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 May 2023
- Primary completion
- 1 Feb 2034
- Completion
- 1 Feb 2037
- Last update posted
- 27 Apr 2026
- Registered enrollment
- 1,300
- Registry id
- NCT05705401
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.